Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis

Stem Cell Research

Volumn 11, Issue 2, 2013, Pages 834-844

  Maumus, Marie ^a,b   Manferdini, Cristina ^c   Toupet, Karine ^a,b   Peyrafitte, Julie Anne ^d   Ferreira, Rosanna ^e   Facchini, Andrea ^c   Gabusi, Elena ^c   Bourin, Philippe ^d,f   Jorgensen, Christian ^a,b,e   Lisignoli, Gina ^c   Noël, Danièle ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f HÔpital Lapeyronie ^*

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CAMPTOTHECIN; CD34 ANTIGEN; COLLAGEN TYPE 2; ENDOGLIN; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; INTERSTITIAL COLLAGENASE; MICROSOMAL AMINOPEPTIDASE; NEUTRALIZING ANTIBODY; SCATTER FACTOR; THROMBOSPONDIN 1; THY 1 ANTIGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL DEGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CLINICAL ARTICLE; COCULTURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOCYTES; ADULT; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOARTHRITIS; PHENOTYPE;

EID: 84879579704     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.05.008     Document Type: Article

References (47)

1. Acharya C., Adesida A., Zajac P., Mumme M., Riesle J., Martin I., Barbero A. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J. Cell. Physiol. 2012, 227:88-97.
2. Aung A., Gupta G., Majid G., Varghese S. Osteoarthritic chondrocyte-secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum. 2011, 63:148-158.
3. Bau B., McKenna L.A., Soeder S., Fan Z., Pecht A., Aigner T. Hepatocyte growth factor/scatter factor is not a potent regulator of anabolic and catabolic gene expression in adult human articular chondrocytes. Biochem. Biophys. Res. Commun. 2004, 316:984-990.
4. Biernacka A., Dobaczewski M., Frangogiannis N.G. TGF-beta signaling in fibrosis. Growth Factors 2011, 29:196-202.
5. Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377:2115-2126.
6. Bohm B., Hess S., Krause K., Schirner A., Ewald W., Aigner T., Burkhardt H. ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis. Arthritis Rheum. 2010, 62:1372-1382.
7. Bouffi C., Bony C., Courties G., Jorgensen C., Noel D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 2010, 5:e14247.
8. Bouffi C., Thomas O., Bony C., Giteau A., Venier-Julienne M.C., Jorgensen C., Montero-Menei C., Noel D. The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 2010, 31:6485-6493.
9. Bourin P., Peyrafitte J.A., Fleury-Cappellesso S. A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use. Methods Mol. Biol. 2011, 702:331-343.
10. Dankbar B., Neugebauer K., Wunrau C., Tibesku C.O., Skwara A., Pap T., Fuchs-Winkelmann S. Hepatocyte growth factor induction of macrophage chemoattractant protein-1 and osteophyte-inducing factors in osteoarthritis. J. Orthop. Res. 2007, 25:569-577.
11. Diekman B.O., Wu C.L., Louer C.R., Furman B.D., Huebner J.L., Kraus V.B., Olson S.A., Guilak F. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents post-traumatic arthritis. Cell Transplant. 2013, (2012 Aug 10, Epub ahead of print, in press).
12. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
13. Doorn J., Moll G., Le Blanc K., van Blitterswijk C., de Boer J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng. Part B Rev. 2012, 18:101-115.
14. Fischer J., Dickhut A., Rickert M., Richter W. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum. 2010, 62:2696-2706.
15. Giovannini S., Diaz-Romero J., Aigner T., Heini P., Mainil-Varlet P., Nesic D. Micromass co-culture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro. Eur. Cell. Mater. 2010, 20:245-259.
16. Guevremont M., Martel-Pelletier J., Massicotte F., Tardif G., Pelletier J.P., Ranger P., Lajeunesse D., Reboul P. Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. J. Bone Miner. Res. 2003, 18:1073-1081.
17. Hunter D.J. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat. Rev. Rheumatol. 2011, 7:13-22.
18. Inoue T., Okada H., Kobayashi T., Watanabe Y., Kanno Y., Kopp J.B., Nishida T., Takigawa M., Ueno M., Nakamura T., Suzuki H. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J. 2003, 17:268-270.
19. Jurgens W.J., Oedayrajsingh-Varma M.J., Helder M.N., Zandiehdoulabi B., Schouten T.E., Kuik D.J., Ritt M.J., van Milligen F.J. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res. 2008, 332:415-426.
20. Jurgens W.J., van Dijk A., Doulabi B.Z., Niessen F.B., Ritt M.J., van Milligen F.J., Helder M.N. Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy 2009, 11:1052-1064.
21. Lee W.J., Park S.E., Rah D.K. Effects of hepatocyte growth factor on collagen synthesis and matrix metalloproteinase production in keloids. J. Korean Med. Sci. 2011, 26:1081-1086.
22. Lin C.S., Ning H., Lin G., Lue T.F. Is CD34 truly a negative marker for mesenchymal stromal cells?. Cytotherapy 2012, 14:1159-1163.
23. Liu X., Sun H., Yan D., Zhang L., Lv X., Liu T., Zhang W., Liu W., Cao Y., Zhou G. In vivo ectopic chondrogenesis of BMSCs directed by mature chondrocytes. Biomaterials 2010, 31:9406-9414.
24. Liu X., Shen W., Yang Y., Liu G. Therapeutic implications of mesenchymal stem cells transfected with hepatocyte growth factor transplanted in rat kidney with unilateral ureteral obstruction. J. Pediatr. Surg. 2011, 46:537-545.
25. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012, 64:1697-1707.
26. Manferdini C., Maumus M., Gabusi E., Piacentini A., Filardo G., Peyrafitte J.-A., Jorgensen C., Bourin P., Fleury-Cappellesso S., Facchini A., Noël D., Lisignoli G. Adipose stromal cells exert anti-inflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients: via PGE2. Arthr. Rheum. 2013, 65:1271-1281.
27. Maumus M., Guerit D., Toupet K., Jorgensen C., Noel D. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res. Ther. 2011, 2:14.
28. Maumus M., Peyrafitte J.A., D'Angelo R., Fournier-Wirth C., Bouloumie A., Casteilla L., Sengenes C., Bourin P. Native human adipose stromal cells: localization, morphology and phenotype. Int. J. Obes. (Lond) 2011, 35:1141-1153.
29. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009, 20:419-427.
30. Mo X.T., Guo S.C., Xie H.Q., Deng L., Zhi W., Xiang Z., Li X.Q., Yang Z.M. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs. Bone 2009, 45:42-51.
31. Murphy J.M., Fink D.J., Hunziker E.B., Barry F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003, 48:3464-3474.
32. Nakamura T., Sakai K., Nakamura T., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J. Gastroenterol. Hepatol. 2011, 26(Suppl. 1):188-202.
33. Pfander D., Cramer T., Weseloh G., Pullig O., Schuppan D., Bauer M., Swoboda B. Hepatocyte growth factor in human osteoarthritic cartilage. Osteoarthritis Cartilage 1999, 7:548-559.
34. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
35. Salgado A.J., Reis R.L., Sousa N.J., Gimble J.M. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr. Stem Cell Res. Ther. 2010, 5:103-110.
36. Schipper B.M., Marra K.G., Zhang W., Donnenberg A.D., Rubin J.P. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann. Plast. Surg. 2008, 60:538-544.
37. Shabbir A., Zisa D., Suzuki G., Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1888-H1897.
38. Sherriff-Tadano R., Ohta A., Morito F., Mitamura M., Haruta Y., Koarada S., Tada Y., Nagasawa K., Ozaki I. Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism. Mod. Rheumatol. 2006, 16:364-371.
39. Skalnikova H., Motlik J., Gadher S.J., Kovarova H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2011, 11:691-708.
40. Song Y.S., Lee H.J., Doo S.H., Lee S.J., Lim I., Chang K.T., Kim S.U. Mesenchymal stem cells over-expressing hepatocyte growth factor (HGF) inhibit collagen deposit and improve bladder function in rat model of bladder outlet obstruction. Cell Transplant. 2012, 21(8):1641-1650.
41. Takebayashi T., Iwamoto M., Jikko A., Matsumura T., Enomoto-Iwamoto M., Myoukai F., Koyama E., Yamaai T., Matsumoto K., Nakamura T., et al. Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes. J. Cell Biol. 1995, 129:1411-1419.
42. Ter Huurne M., Schelbergen R., Blattes R., Blom A., de Munter W., Grevers L.C., Jeanson J., Noel D., Casteilla L., Jorgensen C., van den Berg W., van Lent P.L. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012, 64:3604-3613.
43. van der Kraan P.M., Goumans M.J., Blaney Davidson E., ten Dijke P. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res. 2012, 347:257-265.
44. Vinatier C., Bouffi C., Merceron C., Gordeladze J., Brondello J.-M., Jorgensen C., Weiss P., Guicheux J., Noel D. Cartilage engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr. Stem Cell Res. Ther. 2009, 4:318-329.
45. Wu L., Leijten J.C., Georgi N., Post J.N., van Blitterswijk C.A., Karperien M. Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng. Part A 2011, 17:1425-1436.
46. Wu L., Prins H.J., Helder M.N., van Blitterswijk C.A., Karperien M. Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng. Part A 2012, 18:1542-1551.
47. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.